Vaccine Controversy Continues

Children and Adults Still Being Injured by Dangerous Ingredients in Common Vaccines

“By four to five months of age, only 25-45% of babies now have protective levels of measles antibody,” declared a 2009 BBC News report, referring to a study published in Archives of Diseases in Childhood. The article explained that: “Before measles vaccine was introduced in 1968, very young babies had some temporary protection from antibodies passed from their mother…But because most mothers now have vaccine-mediated immunity rather than natural immunity against measles, that protection in babies is less than it was.”

In 2011, a large outbreak of measles occurred among Quebec high school students, more than half of whom had been fully vaccinated as babies. Dr. Gaston De Serres, an expert in infectious diseases, noted that antibodies received by breastfed babies may prevent infection from the live measles vaccine virus as well as natural measles virus; he therefore wondered if the MMR vaccine doses injected at 12 and 18 months should be delayed in order to allow the maternal antibodies to wane – then the vaccine virus could initiate infection and measles antibodies could be elicited artificially.

A similar effect is noted in a 2010 study which concludes that breastmilk consumed at the time when babies receive rotavirus vaccine may reduce the vaccine’s potency; the authors suggest that breastmilk be withheld to allow the vaccine to be infectious and therefore, efficacious!

Live-Virus Vaccines Backfire

Although the viruses used in live-virus vaccines – including varicella (chickenpox), MMR (measles, mumps, rubella), rotavirus, some influenza vaccines, plus the oral polio vaccine – have been weakened with the intent of avoiding symptomatic infection, this weakening is not foolproof. For instance, the 2013 product monograph for Priorix-Tetra® MMR-varicella vaccine lists “measles-like, rubella-like and varicella-like rash” as “common” reactions, and parotid swelling (mumps) as “uncommon” ones (up to 1% affected). It warns that the vaccine should not be given to pregnant women and, “Further-more, pregnancy should be avoided for three months after vaccination.” The word “Confidential” appears at the top of every page of this monograph.

CHICKENPOX VACCINE – Because dormant varicella zoster virus remaining from a case of chickenpox can subsequently cause shingles, chickenpox vaccine can be even more troublesome. In the cases where the first dose of vaccine and booster do prevent chickenpox, the incidence of shingles, a much more severe disease, has been shown to rise in children and adults. This has occurred because less circulating varicella virus also allows less boosting of natural immunity to shingles. Health authorities now recommend yet another live virus vaccine which is supposed to prevent shingles in adults 50 years and older.

INFLUENZA VACCINE – aka the ‘flu shot,’ provides a very obvious example of ineffectiveness, and not just because influenza viruses are ever-changing. Authors of a recent review of gold-standard research published between 1967 and 2011 found that, even when the vaccine’s viral strains were the same as those circulating amongst the public, the flu shot appeared to be no more effective than when they were different from those circulating. (Nevertheless, healthcare workers have been pressured to accept the shot in order to protect their patients!) Especially questionable is the live virus nasal spray vaccine which can cause influenza symptoms in recipients and their contacts.

POLIO VACCINE – For twenty five years, the ‘polio eradication’ program has used live oral polio vaccine (OPV). India’s 2012 and 2013 surveillance of acute flaccid paralysis (AFP) – of which only a tiny portion is due to polio – shows no detections of wild polio virus, but thousands of cases with vaccine-type polio virus plus a few cases with vaccine derived polio virus, ie. virus which originates from the vaccine but has mutated. However, the World Health Organization intends to fix the problem. It has a plan which “addresses the eradication of all polio disease, whether caused by wild poliovirus or circulating vaccine-derived poliovirus” by 2018. The plan includes shifting from OPV to killed virus vaccine and increasing the already-aggressive vaccination rates.

But there’s a much more urgent problem than polio eradication. A 2012 study states that, “Data from India on polio control over 10 years, available from the National Polio Surveillance Project, has now been compiled…This shows that the non-polio AFP rate increases in proportion to the number of polio vaccine doses received…These findings point to the need for a critical appraisal to find the factors contributing to the increase…perhaps looking at the influence of strain shifts of entero-pathogens induced by the vaccine given practically once every month [ie, because frequent vaccine doses have reduced wild polio virus so radically, other non-polio gut pathogens which can cause AFP may have taken its place].”

HPV VACCINE – contains “virus-like particles,” not live viruses, but deserves special mention. Its main raison d’être is supposedly to prevent cervical cancer. This effect has never been proven; in fact, pre-licensing trials suggested it could actually cause cancer in women testing positive for HPV. A U.S. CDC 2013 study concludes that, among females aged 14 to 19 years – and despite low vaccine uptake – the vaccine-type HPV prevalence had declined by 56% from the last four years pre-vaccine. The sample size was inadequate, HPV testing methods did not meet clinical standards, the data collected allowed only estimates of vaccine-type HPVs, and data from girls who’d not been sexually active was excluded. Nevertheless, media faithfully regurgitated CDC’s “surprising” results.

Bacterial Vaccines and Shifting Strains

PERTUSSIS VACCINE – has been widely used since the late 1940s, yet pertussis disease is still with us. In fact, recommendations have been increased to the point that we’re now expected to accept continual doses cradle to grave. In Britain, at a time when DTP (diphtheria-tetanus-pertussis vaccine) uptake decreased then increased, meningococcal deaths of newborns to 4 year olds also decreased then increased. This link is corroborated by numerous studies which show a correlation between pertussis vaccines and systemic bacterial infections from several different organisms, especially Haemophilus influenzae b (Hib). A June 1992 issue of Newsletter from the Journal of Pediatric Infectious Diseases stated: “We have great concern for the increasing prevalence of relatively or absolutely penicillin-resistant pneumococci coupled with the increased relative frequency of pneumococcal diseases as a result of universal Haemophilus vaccination.” Note that pneumococcal disease is much more serious and antibiotic-resistant than Hib has ever been.
In fact, the relative prevalence of the various strains of Haemophilus has also been changing such that Hib vaccine is less effective than expected. Nevertheless, Hib vaccine remains in current “safe and effective” vaccine schedules.

PNEUMOCOCCAL VACCINE (STREP) – The pneumococcal disease increase could not be so easily ignored; a vaccine containing seven pneumococcal strains was introduced in 2002. A 2008 Canadian study found that a little-known but potentially fatal lung infection named empyema had increased by 30% between 1995 and 2003, the rate increasing more than 450% in children one to four years old. Head researcher, Dr. Christian Finley, and his team suggested that pressure from the new vaccine had increased a pneumococcal strain which was not included in the vaccine and is the most common cause of the empyema. They also suggested that there would be an even greater shift from a prevalence of pneumococci to one of Staphylococci or E coli bacteria.

A ten-valent vaccine was introduced in 2009, a thirteen-valent one in 2010. The most recent pneumococcal vaccine recommendations were made in 2010, at which time the National Advisory Committee on Immunization (NACI) was unsure “whether three-dose schedules are non-inferior to four-dose schedules for healthy children.” Note that approximately 90 serotypes of Streptococcus pneumonia, the bacterium associated with pneumococcal disease (also known as strep), have been identified, and their occurrence varies among different age groups and locations as well as at different times.

MENINGOCOCCAL VACCINE – The effectiveness of meningococcal vaccine is also in doubt. A 2010 cross-Canada study shows that, since 2006, the meningococcal C vaccine introduced in 2003 was largely ineffective for prevention of invasive meningococcal disease (IMD) in children; from 2006 to 2009, the incidence of B was 69% whereas that of C was 5%. A 2010 NACI statement reviewed past recommendations including one in 2007 for meningococcal vaccine containing serogoups A, Y and W135 as well as C – none of which were as prevalent as B. As if to substitute boosters for absent B strains, the 2010 recommendation was that “a dose of meningococcal conjugate vaccine be offered in early adolescence…even if the adolescent was previously vaccinated”.
The problem is that the B strains are much more challenging for vaccine developers.

But a Feb 2012 newswire stated: “The Journal of the American Medical Association published a study today that shows Bexsero™ induced a sufficient immune response against meningococcal B disease in the majority of infants vaccinated.” The following year, the UK’s Joint Committee on Vaccination and Immunization rejected the new vaccine, explaining that “there was not enough evidence that Bexsero, developed by the Swiss pharmaceutical giant Novartis, would protect children well enough to justify routine vaccination.” The 2010 NACI statement has yet to be updated. Perhaps this is due to the lack of evidence and more. It notes that, “Because of the short incubation period of IMD (range 2 to 10 days, commonly 3 to 4 days) it is now generally accepted that the anamnestic [antibody memory] response cannot be relied upon to prevent disease and that circulating antibodies [from previous infection or repeated recent vaccination] are necessary for protection.”

Maintaining Good Health the Natural Way

Breastfeeding is a most critical factor in ensuring healthy child development and a foundation for strong immunity for life. Kelly Brogan, MD, identifies herself as “a staunch advocate for the impossible-to-replicate complexity of breastmilk, as well as the anti-inflammatory benefits to the mother.” She warns about factors which can limit breastmilk production: infrequent feeding, use of pacifiers, limited lactation support and resources, insufficient encouragement, and aggressive promotion of formula feeding and supplementation. She suggests several things to do both before and after the baby is born to help ensure a plentiful breastmilk supply: avoid Bisphenol A, chlorine, pesticides and parabens; consume chlorella or other natural detoxifiers such as turmeric, cilantro and garlic; and adopt a low glycemic diet which is high in natural fats and proteins, especially one which avoids processed and artificial sugars and refined flour. To help manage toxins, she suggests reducing stress with breathing techniques, meditation and exercise, advising: “Take action in ways large and small to help your bodies do what they know how to do best…achieve natural balance.”

Studies from the 1980s and earlier show that even minor vitamin and mineral deficiencies, sub-clinical malnutrition, or brief periods of sleep deprivation can seriously impair immunity to infections. They also leave no doubt that alcohol and cigarettes are immunosuppressive. On the other hand, physical exercise can elevate our bodies’ interferon, a protein which arrests viral replication. And the immune-enhancing effects of sunlight have been researched for more than a century; one study, ‘Research on the Effect of Light Upon Bacteria and Other Organisms’ was published in Proceedings of the Royal Society of Medicine in 1877.

Numerous helpful articles are published in every issue of Vitality Magazine. One example is Dr Rona’s ‘Boost Your Immune System: All the Best Alternatives to Vaccination’ in the Sept 2012 edition; it complemented my first contribution, ‘Vaccine Controversy’.

Susan Fletcher is President, and for the last 13 yrs has been a member, of Canada’s Vaccination Risk Awareness Network Inc – see


‘Baby measles immune boost call’; BBC News; May 30, 2009
‘Quebec hit by measles outbreak’; CBC News; Apr 28, 2011
‘Measles among vaccinated kids raises questions’; CTV news; Oct 20, 2011
Moon, Sung-Sil PhD et al; Inhibitory Effect of Breast Milk on Infectivity of Live Oral Rotavirus Vaccines; Pediatric Infectious Disease Journal; Oct 2010; Vol 29, Issue 10. 10000/Inhibitory_Effect_of_Breast_Milk_on_Infectivity_of.7.aspx
Product Monograph: Priorix-Tetra® combined measles, mumps, rubella and varicella vaccine, live, attenuated; pgs 5-6
Goldman G S and King P G; Review of the US universal varicella vaccination program; Vaccine; Mar 25, 2013; Vol 31, Issue 13.
Product Monograph: Zostavax Live, attenuated virus varicella-zoster vaccine
‘Flu shot science trashed’
‘Flumist live virus influenza vaccine – best to hold your nose?   
‘Paralysis/death surge’
AFP Surveillance Bulletin – India; Table 4, Intratypic differentiation (ITD) of isolates from AFP cases
‘Polio Eradication and Endgame Strategic Plan 2013-2018’; WHO
Vashisht N and Puliyel; Polio programme: let us declare victory and move on; Indian Journal of Medical Ethics; Apr-June 2012; Vol IX No 2.
HPV Vaccine – “Cervical Cancer Vaccine”
“HPV Vaccines: Resounding success or future failure?’ by Norma Erickson; July 22, 2013
‘The vaccines: Pediacel, Infanrix hexa, Adacel Polio and Adacel’; Overview of Acellular Pertussis Vaccine and Overview of Haemophilus Influenzae type b vaccine (Hib) 
‘Pneumococcal Disease Vaccine’
‘Pneumococcal Diseases and their Vaccine’
‘Update on the use of Conjugate Pneumococcal Vaccines in Childhood’; NACI; Nov 2010; Vol 36, ACS-12
‘Meningococcal Diseases and Vaccine’
‘Pivotal study published in JAMA confirms potential of Novartis (1) Bexsero™ to help protect infants’; CNW; Feb 9 2012
‘Meningitis B vaccine rejected by UK’ by Sarah Boseley; The Guardian; July 24, 2013
An analysis of the influenza vaccine enterprise; Center for Infectious Disease Research & Policy, U of Minnesota; Oct 2012; pg 21.
‘Universal Immunization: Medical Miracle of Masterful Mirage’ by Dr Raymond Obomsawin; 1998; Section I; Early Theoretical Foundations Re-examined, and its References, and Antibody Theory
‘Vaccinomics: Scientists Are Devising Your Personal Vaccine’ by Melinda W Moyer; Scientific American; June 24, 2010
Tan, Poh-Lin et al; Twin studies of immunogenicity – determining the genetic contribution to vaccine failure; Vaccine; Mar 21, 2001; Vol 19, Issues 17-19.
‘Ensuring Plentiful Breastmilk Supply Starts Before Baby is Born’ by Kelly Brogan MD; the healthy Home Economist; Aug 22, 2013
‘Universal Immunization: Medical Miracle of Masterful Mirage’ by Dr Raymond Obomsawin; 1998; Section III; General Conclusions on Appropriate Alternatives


Susan Fletcher is Past President and has been a member of VRAN for fourteen years. For further information, please refer to her previous articles in Vitality’s September 2012 and October 2013 issues or email

Write a Comment

view all comments